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To assess experimental virulence among sequence type 131 (ST131) Escherichia coli
bloodstream isolates in relation to virulence genotype and subclone.
Methods
We analysed 48 Spanish ST131 bloodstream isolates (2010) by PCR for ST131 subclone
status (H30Rx, H30 non-Rx, or non-H30), virulence genes (VGs), and O-type. Then we
compared these traits with virulence in a murine sepsis model, as measured by illness
severity score (ISS) and rapid lethality (mean ISS 4).
Results
Of the 48 study isolates, 65% were H30Rx, 21% H30 non-Rx, and 15% non-H30; 44% pro-
duced ESBLs, 98% were O25b, and 83% qualified as extraintestinal pathogenic E. coli
(ExPEC). Of 49 VGs, ibeA and iss were associated significantly with non-H30 isolates, and
sat, iha and malX with H30 isolates. Median VG scores differed by subclone, i.e., 12
(H30Rx), 10 (H30 non-Rx), and 11 (non-H30) (p < 0.01). Nearly 80% of isolates represented
a described virotype. In mice, H30Rx and non-H30 isolates were more virulent than H30
non-Rx isolates (according to ISS [p = 0.03] and rapid lethality [p = 0.03]), as were ExPEC
isolates compared with non-ExPEC isolates (median ISS, 4.3 vs. 2.7: p = 0.03). In contrast,
most individual VGs, VG scores, VG profiles, and virotypes were not associated with mouse
virulence.
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Conclusions
ST131 subclone and ExPEC status, but not individual VGs, VG scores or profiles, or viro-
types, predicted mouse virulence. Given the lower virulence of non-Rx H30 isolates, hyper-
virulence probably cannot explain the ST131-H30 clade’s epidemic emergence.
Introduction
The spread of a specific Escherichia coli clone called sequence type 131 (ST131) is one of the
key drivers of the rising prevalence of resistance to quinolones and cephalosporins among E.
coli that cause urinary tract infections, with cephalosporin resistance being mainly due to
expression of extended-spectrum beta-lactamases (ESBLs), particularly CTX-M-15 [1–3]. The
as-yet-unknown reasons for this globally distributed clone’s epidemic success are under active
investigation [4].
The ST131 pandemic is driven mainly by two nested subclones within ST131, i.e.,H30 (or
clade C), which contains allele 30 of fimH (type 1 fimbriae), andH30Rx (or clade C2), a subli-
neage within H30 that often expresses CTX-M-15 [4]. Strains that encode alleleH30 but do
not produce CTX-M-15 are usually grouped in theH30 non-Rx subclone (or Clade C1). Sev-
eral studies have suggested that, apart from being extensively resistant, ST131 is also highly vir-
ulent, with a higher capability of causing infection than other strains [5,6]. ST131 virulence has
been assessed in different animal models [7–9] with different conclusions. Moreover, these
studies have not addressed ST131 subclone status.
ST131 usually contains a high number of putative virulence genes (VGs) which probably
contributes to its virulence [7]. Indeed, in multiple studies, ST131 has been associated with
specific VGs, including usp (uropathogenic specific protein), iutA (aerobactin receptor), fyuA
(yersiniobactin receptor), ompT (outer membrane protein T), and iroN (salmochelin receptor)
[10–14], which variously encode for toxins, adhesins, siderophores, or outer membrane pro-
teins. Moreover, within ST131, based on specific combinations of VGs some authors have
described virotypes A, B, C, D (with subsets 1–5), and E [10,15,16]. Of these virotypes, A, B
and C have been associated with higher experimental virulence [15].
Hence, we sought to clarify these relationships among ST131 isolates from Spain by study-
ing 48 ST131 isolates, including representatives of the different ST131 subclones. Specifically,
we characterized our ST131 isolates extensively in vitro, assessed their virulence in a murine
sepsis model, and sought correlations between experimental virulence and VG content, viro-
type, ExPEC status, and ST131 subclone (H30Rx,H30 non-Rx, and non-H30).
Material and methods
Isolates and detection of ST131 subclones and O types
The present ST131 study isolates represented a subset of the ITU-BRAS collection, the product
of a Spanish multicentre study of bloodstream isolates from patients with bacteraemia of uri-
nary origin who were admitted in 8 hospitals of different geographic areas from October 2010
to June 2011 [17]. This study was approved by the Ethics Commitee for Clinical Research of
Hospital Ramón y Cajal. The collection’s 425 E. coli isolates were characterized previously for
ESBL production by PCR and sequencing [18]. Here, they were screened for ST131 status
using PCR-based detection of ST131-specific single-nucleotide polymorphisms (SNPs) within
mdh and gyrB [19]. ST131 isolates were further classified into theH30 and H30Rx subclones
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by PCR-based detection of subclone-specific SNPs [20] and were screened by PCR for the two
most common O types found in ST131 strains, O25b and O16 [21]. For extended virulence
genotyping and testing in the murine sepsis model we selected all ESBL-producing ST131
isolates (n = 21), plus 27 arbitrarily chosen non-ESBL-producing ST131 isolates, giving 48 iso-
lates total. Moreover, to stablish the clonal relationship the 48 ST131 isolates were typed by
PFGE-XbaI and a dendrogram was created using the PFGE-patterns (Bionumerics version 7.5,
Applied Maths NV) according to the unweighted pair group mean arithmetic method based
on pairwise Dice similarity coefficients.
Virulence gene scores and virotypes
Forty-nine putative ExPEC-associated VGs and variants thereof were determined by an estab-
lished multiplex PCR assay (Table 1) [10,22–24]. The VG score was calculated as the total
number of VGs detected, adjusted for multiple detection of the pap (pilus associated with
pyelonephritis, P fimbriae), sfa/foc (S and F1C fimbriae), and kpsII (capsular polysaccharide
synthesis group 2) operons [25]. Isolates were classified as ExPEC if they carried 2 of papAH
and/or papC (counted as one), sfa/foc, afa/dra (Dr antigen specific adhesin), iutA, and kpsMII
[25].
Aggregate VG profiles were defined based on presence/absence of the studied VGs. The
kpsMII and pap operons were considered to be present if any of the corresponding genes or
their allelic variants were detected. Isolates were assigned to virotypes (A, B, C, D1-5, and E) as
described by Mora et al. based on presence/absence of specific VGs: ibeA (invasion of brain
endothelium), iroN, sat (secreted autotransporter toxin), afa/dra, papGII, papGIII, cnf1 (cyto-
toxic necrotizing factor 1), hlyD (ɑ-haemolysin), cdtB (cytolethal distending toxin), and K1
(group II capsule variant) [15]. Isolates not corresponding to a defined virotype were classified
as “other”.
Murine sepsis model
Isolates were tested for in vivo virulence using a modified protocol of an established murine
subcutaneous sepsis model [26]. Experimentation guidelines of the Veterans Affairs Medical
Centre of Minneapolis were followed in the conduct of the mouse model experiments under
animal use protocol 120603, as approved by the local Institutional Animal Care and Use Com-
mittee (IACUC). Mice were kept in ventilated cages (maximum 10 mice per cage) with food
and water ad libitum and following natural cycles of light and darkness. Briefly, female patho-
gen-free outbred Swiss-Webster mice (mean age 60 days, mean weight 23g) were inoculated
subcutaneously in the nape of the neck with approximately 109 CFU/mL log-phase bacteria in
0.2 mL saline. Mouse health was assessed twice daily for 3 days post-challenge. Mice were clas-
sified daily as to maximal illness severity, which ranged from 1 (healthy) to 5 (dead), with
scores 2 (barely ill), 3 (moderately ill) and 4 (severely ill) in between. Scores were based on
external exam of the mice and their behaviour (i.e., redness around the eyes or nose, cleaning
habits, huddling, and movement). The exams were performed concurrently by two experi-
enced investigators who were unaware of the characteristics of the challenge strains, and then
reached a consensus regarding the score. Each particular characteristic was not scored, rather,
all were considered jointly to reach the final illness score. All mice that reached score 4 were
euthanized to minimize suffering. All surviving mice were euthanized at the end of the study
according to the local IACUC guidelines, using carbon dioxide inhalation. All efforts were
taken to minimize suffering of the mice at all times, and no analgesic or anaesthetic was
needed. No unexpected deaths were observed. Each experimental series included a positive
control strain (urosepsis isolate CFT073; 80%-100% of mice dead by 3 days post-challenge)
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and a negative control strain (laboratory strain MG1655; no perceptible mouse illness or
lethality) [26]. Each test strain was assessed initially in 5 mice, followed by another 5 mice if
the initial testing did not yield a consistent result (i.e., lethality or survival for 4 or 5 of the ini-
tially challenged mice).
Daily illness severity scores for the mice challenged with a given isolate were averaged to
give the isolate’s mean illness severity score (ISS). The variables used for comparisons of viru-
lence potential included overall mean ISS (as a continuous variable), rapid lethality (i.e., mean
Table 1. Distribution of virulence genes by ST131 subclones.
Virulence genesa, b N˚ of isolates with genea,b (column %) p valuec








Adhesins papAH 16 (33) 3 (43) 0 (0) 13 (42) 0.67 0.02
papC 17 (35) 5 (71) 0 (0) 12 (39) 0.08 0.02
papEF 17 (35) 5 (71) 0 (0) 12 (39) 0.08 0.02
papGe 15 (31) 3 (43) 0 (0) 12 (39) 0.66 0.02
papGII 13 (27) 1 (14) 0 (0) 12 (39) 0.66 0.02
papGIII 1 (2) 1 (14) 0 (0) 0 (0) 0.15 NA
sfa/foc 1 (2) 1 (14) 0 (0) 0 (0) 0.15 NA
iha 41 (85) 3 (43) 8 (80) 30 (97) < 0.01 0.14
afa/dra 13 (27) 1 (14) 0 (0) 12 (39) 0.66 0.02
hra 17 (35) 4 (57) 0 (0) 13 (42) 0.23 0.02
Toxins hlyD 11 (23) 4 (57) 0 (0) 7 (23) 0.04 0.16
hlyF 7 (15) 3 (43) 1 (1) 3 (10) 0.05 1.0
cnf1 7 (15) 0 (0) 0 (0) 7 (23) 0.57 0.16
cdtB 1 (2) 1 (14) 0 (0) 0 (0) 0.15 NA
sat 41 (85) 2 (29) 9 (90) 30 (97) < 0.01 0.43
Siderophores iroN 6 (13) 3 (43) 0 (0) 3 (10) 0.03 0.56
fyuA 46 (96) 5 (71) 10 (100) 31 (100) 0.02 NA
iutA 45 (94) 5 (71) 9 (90) 31 (100) 0.05 0.24
Protectins and
invasins
kpsMII f 40 (83) 5 (71) 5 (50) 30 (97) 0.33 < 0.01
K1 1 (2) 1 (14) 0 (0) 0 (0) 0.15 NA
K2 25 (52) 2 (29) 0 (0) 23 (74) 0.24 < 0.01
K5 8 (17) 0 (0) 3 (30) 5 (16) 0.58 0.38
K15 1 (2) 1 (14) 0 (0) 0 (0) 0.15 NA
iss 8 (17) 4 (57) 1 (10) 3 (9.7) 0.01 1.0
traT 38 (79) 4 (57) 8 (80) 26 (84) 0.15 1.0
cvaC 4 (8) 1 (14) 1 (10) 2 (6) 0.48 1.0
ibeA 6 (12.5) 6 (83) 0 (0) 0 (0) < 0.01 NA
Other ompT 46 (96) 5 (71) 10 (100) 31 (100) 0.02 NA
malX 44 (92) 3 (43) 10 (100) 31 (100) < 0.01 NA
aGenes detected in all isolates: fimH, yfcV, and usp.
bGenes not detected in any isolate: papGI/I’, sfaS, focG, afaE8, bmaE, gafD, F17, and clpG (adhesins); pic, vat, tsh, astA (toxins); ireA (siderophore);
kpsMTIII and rfc (protectins); and H7 fliC, clbN, and clbB (other).
cP values obtained by chi2 test or Fisher’s test as appropriate. Statistically significant values are in bold.
dH30 included the non-Rx and Rx subsets.
eIsolates with at least one papG allelic variant or that are PCR-positive with generic papG primers.
fIsolates with at least one kpsII variant. NA: Not applicable.
https://doi.org/10.1371/journal.pone.0188838.t001
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illness severity score 4, indicating that all mice were severely ill or dead by day 1 post-
inoculation).
Statistical analysis
Continuous variables were described as medians and interquartile ranges (IQR), and were
compared using the Mann-Whitney or Kruskal-Wallis test, as appropriate. Dichotomous vari-
ables were described using frequencies and percentages, and were compared using a chi-
square test or Fisher’s exact test, as appropriate. The criterion for statistical significance was
p< 0.05. The Bonferroni correction method was applied when multiple comparisons were
performed. Data were analysed with software STATA version 11 (Stata Statistical Software:
Release 11. College Station, TX: StataCorp LP). A heatmap representing presence/absence of
the studied VGs in relation to strain characteristics (subclone, ExPEC status, ISS, virotype and
virulence profile) was performed using RStudio software version 1.0.44 (RStudio Team 2016,




Of the 48 ST131 bloodstream isolates, 31 (65%) were H30Rx, 10 (21%) were H30 non-Rx
and 7 (15%) isolates belonged to the non-H30 subclone. Twenty-one isolates (44%) were
ESBL producers, of which all but one belonged to the H30Rx subclone (Fig 1). By O-type
PCR, 47 isolates (98%) were O25b and one (2%) was O16. The dendrogram showed that
ST131 subclones were evenly distributed across participant hospitals without a clonal over-
representation (Fig 1).
Virulence genes, scores, and ExPEC status
Of the 49 VGs tested, 32 (65%) were detected in at least 1 isolate, at frequencies ranging from
2% to 100% (Table 1) and all isolates encoded at least 8 VGs. All isolates contained fimH, usp,
and yfcV (putative fimbrial subunit). Apart from these, the most prevalent VGs of each func-
tional category were iha (adhesin, 85%), sat (toxin, 85%), fyuA (siderophore, 96%), kpsMII
(protectin, 83%), and ompT (other, 96%).
The three ST131 clonal subsets (H30Rx,H30 non-Rx, and non-H30) differed significantly
for the prevalence of certain VGs (Table 1). Whereas ibeA (83%) and iss (57%) were found
mainly in non-H30 isolates (versus 0% and 10% inH30-positive isolates respectively,
p 0.01),malX (100%), sat (95%) and iha (93%), were detected more commonly among the
H30 isolates (versus 43%, 29% and 43% respectively among the non-H30 isolates, p< 0.01).
Moreover, the VGs kpsII and K2 differed significantly in prevalence between theH30Rx and
H30 non-Rx isolates (97% versus 50% and 74% versus 0% respectively, p< 0.01). Also of note,
theH30 non-Rx isolates did not encode any VG of the pap operon and in fact the only adhe-
sins found in this subclone were fimH, yfcV and iha.
Overall, VG scores ranged from 8 to 17 (median 12, IQR 10.5–14). Scores differed by sub-
clone, with medians (IQR) of 12 (11–15) forH30Rx, 11 (10–14) for non-H30 isolates, and 10
(10–10) forH30 non-Rx (p< 0.01 for the three-group comparison). ESBL production was
associated with higher VG score with median (IQR) VG score of 13 (12–15) in ESBL producers
versus 10 (10–13) in non-ESBL producers (p<0.01).
Forty (83%) study isolates fulfilled molecular criteria for ExPEC, including all 31H30Rx
isolates (100%) and 71% (5/7) of non-H30 isolates but only 40% (4/10) ofH30 non-Rx isolates
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(versus H30Rx: p< 0.01) (Table 2). ExPEC isolates showed higher VG scores than non-ExPEC
isolates (median 12 versus 10: p< 0.01).
Virotypes and virulence profiles
Overall, 79% (38/48) of isolates corresponded with a previously described virotype, most com-
monly virotype C (31%) or A (25%) (Table 3). Virotype C occurred within all three subclones
(16% ofH30Rx, 90% ofH30 non-Rx, and 14% of non-H30 isolates), while the other virotypes
were found exclusively in certain subclones (Table 2). Moreover, virotypes differed signifi-
cantly for VG scores (p< 0.01 overall) with virotype B and E showing the highest VG score
with median of 15 (IQR 15–15) (Table 3).
Twenty-three different VG profiles (arbitrarily numbered P1 to P23) were observed (Fig 2).
Diversity of profiles varied by clonal subset, that is, whereas collectively the 31H30Rx isolates
showed only 12 total profiles, and the 10H30 non-Rx isolates only 6 total profiles, each of the 7
non-H30 isolates had a unique profile.
Murine sepsis model
Overall, the 48 study isolates showed a high level of morbidity and lethality in the murine sep-
sis model: the median ISS was 4.3 (IQR 2.8–4.7), and 29 (60%) were rapidly lethal. ESBL
Fig 1. Dendrogram of the 48 ST131-E. coli. Hospitals: 03-Hospital Gregorio Marañón (Madrid); 04-Hospital
del Mar (Barcelona) 05-Hospital Marqués de Valdecilla (Santander); 07-Hospital Ramón y Cajal (Madrid);
08-Hospital de la Santa Creu i San Pau (Barcelona); 09-Hospital Virgen Macarena (Sevilla); 10-Complejo
Sanitario de Pontevedra (Pontevedra); 11-Hospital Mutua Tarrassa (Barcelona). VG profile: Virulence genes
profile. VP: Virulence profile.
https://doi.org/10.1371/journal.pone.0188838.g001
Table 2. Virulence genes scores, ExPEC status, and experimental virulence according to subclone and virotype.
Virulence-related genotypes Mouse sepsis model outcomes
ST131 Subclone Virotypes (no. isolates) Median VGa score (IQRd) ExPEC (row %) Median ISSb (IQRd) Rapid lethality (row %)
Non-H30 C (n = 1) 10 (0) 0 (0) 4.4 (0) 1 (100)
D3 (n = 1) 11 (0) 1 (100) 4.5 (0) 1 (100)
D4 (n = 1) 10 (0) 0 (0) 1.7 (0) 0(0)
Otherc (n = 4) 13.5 (3.5) 4 (100) 4.5 (1.4) 3 (75)
Total (n = 7) 11 (3) 5 (71) 4.4 (2.4) 5 (71)
H30 non-Rx C (n = 9) 10 (0) 4 (44) 2.9 (1.6) 3 (33)
Other (n = 1) 8 (0) 0 (0) 1.5 (0) 0 (0)
Total (n = 10) 10 (0) 4 (40) 2.75 (1.9) 3 (30)
H30Rx A (n = 12) 12 (1) 12 (100) 4.5 (0.75) 9 (75)
B (n = 2) 15 (0) 2 (100) 3.4 (1.8) 1 (50)
C (n = 5) 11 (0) 5 (100) 4.1 (2) 3 (60)
E (n = 7) 15 (0) 7 (100) 3.9 (1.7) 3 (43)
Other (n = 5) 13 (0) 5 (100) 4.7 (0.3) 5 (100)
Total (n = 31) 12 (4) 31 (100) 4.3 (1.5) 21 (68)
aVG: virulence gene.
bISS: illness severity score.
c”Other”: isolates that did not correspond with a defined virotype.
d IQR: Interquartile range
https://doi.org/10.1371/journal.pone.0188838.t002
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Table 3. Prevalence of characteristics (column %) and median scores according to virotypes.
Virotype
Charac.b A (n = 12) B (n = 2) C (n = 15) D3 (n = 1) D4 (n = 1) E (n = 7) Othera (n = 10)
ExPEC 12 (100) 2 (100) 9 (60) 1 (100) 0 (0) 7 (100) 9 (90)
VG score (IQR)c 12 (1) 15 (0) 10 (1) 10.5 (0) 10 (0) 15 (0) 13 (1)
ISS (IQR)d 4.5 (0.75) 3.4 (1.8) 3.8 (2) 4.5 (0) 1.7 (0) 3.9 (1.7) 4.6 (0.4)
RLe (col. %) 9 (75) 1 (50) 7 (47) 1 (100) 0 (0) 3 (43) 8 (80)
aOther: isolates did not correspond with a defined virotype.
bCharacteristics: For comparisons across all virotypes, the only statistically significant difference involved virulence gene scores (p < 0.01).
c VG score: Median virulence gene score (interquartile range).
d ISS: Median illness severity score (interquartile range).
e Rapid lethality.
https://doi.org/10.1371/journal.pone.0188838.t003
Fig 2. Heatmap with the virulence genes tested of the 48 Escherichia coli ST131 study isolates. Only variably present
virulence genes are shown, with all pap and kps variants counted as one; pap: isolates positive for any of the pap operon genes
tested, i.e., papAH, papC, papEF, papG (with alleles I, I’, II, III), kps II: isolates positive for any of the kps II variants tested, i.e.,
kpsMII, K1, K2, K5 and K15. Virulence genes present or absent in all isolates are not shown. Red indicates presence and green
indicates absence of gene. “Other” category (virotype column): a virotype could not be assigned. ISS: illness severity score. RL:
rapid lethality. Profile (P): Aggregated virulence genes profile.
https://doi.org/10.1371/journal.pone.0188838.g002
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producers showed greater illness severity (median ISS, 4.4 for ESBL producers, versus 4.1 for
non-ESBL producers: p = 0.04) and were more often rapidly lethal (71% versus 52%, p = 0.17).
By clonal subset, theH30Rx and non-H30 isolates exhibited the greatest illness severity
(median ISS, 4.3 and 4.4, respectively), andH30 non-Rx isolates the lowest (median ISS, 2.75;
versus other isolates: p = 0.04). Likewise, mostH30Rx and non-H30 isolates exhibited rapid
lethality (71% and 68%, respectively), as compared with only 30% ofH30 non-Rx isolates
(H30Rx versus H30 non-Rx: p = 0.06) (Table 2).
The illness severity score was also greater in ExPEC isolates (median ISS, 4.3 [ExPEC] versus
2.7 [non-ExPEC]: p = 0.03). In contrast, VG scores and aggregate VG profiles were not signifi-
cantly associated with any sepsis model outcome, and among individual VG, only K2 was asso-
ciated with higher ISS (median 4.45 in K2-positive isolates versusmedian 3.35 in K2-negative
isolates, p < 0.01). Moreover, virotype A and D3 isolates showed the highest median ISS (4.5)
although neither of them had the highest VG score and there was no significant overall associa-
tion between virotype and these virulence outcomes (Table 2).
Discussion
In this study, we assessed 48 Spanish E. coli ST131 bloodstream isolates for VG content
(expressed as individual VGs, ExPEC status, VG scores, VG profiles, and virotypes) and ST131
subclone status, and compared these bacterial characteristics with virulence in a murine sepsis
model (expressed as ISS, and rapid lethality).
We found no significant association of in vivo virulence with VG scores, extended VG pro-
files, or virotypes. Moreover, among the 49 VG studied, the only one that was associated with a
higher ISS was K2, which encodes certain capsular antigen variants K2. Although ESBL pro-
duction seemed possibly to be associated with higher VG score and ISS, almost all (20/21)
ESBL-producing isolates belonged to theH30Rx subclone, so this association could result
from confounding factors. Also, the K2 gene was detected more often amongH30Rx isolates
(74%) than in the other isolates (17%), which also points to subclone classification as the rea-
son for this association. In contrast, the ST131 subclones and ExPEC versus non-ExPEC iso-
lates differed significantly for in vivo virulence. These differences suggest that the bacterial
traits determining experimental virulence in this murine model are distributed differentially
between ST131 clonal subsets, and between ExPEC versus non-ExPEC ST131 isolates, but do
not necessarily include the VGs studied here or segregate reliably by virotype. Moreover, these
data could indicate that the recent epidemic expansion of theH30 ST131 subclone–at least its
large non-Rx component–must have explanations other than hyper-virulence, at least as mea-
sured in this murine sepsis model. Indeed, in this study theH30 non-Rx isolates showed a
noticeable lack of VGs (mainly adhesins), specially compared with the phylogenetically related
H30Rx subclone.
Overall, the present ST131 isolates exhibited high in vivo virulence, as described previously
for other ST131 isolates [5,15]. However, we found in vivo virulence to vary considerably both
between and within the different ST131 subclones, consistent with the findings of Johnson
et al [9]. This variability in experimental virulence between and within ST131 subsets may
explain why no consistent lethality differences have been found between ST131 isolates gener-
ally and non-ST131 isolates [9,15].
TheH30 subset within ST131, with its Rx and non-Rx components, is the leading cause of
ST131 expansion [20]. Interestingly, in the present comparison of experimental virulence and
VG content, theH30Rx isolates more closely resembled the non-H30 isolates than they did the
H30 non-Rx isolates, which conflicts with the underlying phylogenetic relationships. Subclone
differentiation was not considered in previous reports from several authors that described
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variability among experimental virulence in ST131 strains and the lack of correlation between
virulence gene content and experimental virulence [15,16,21]. Our results indicate that sub-
clones should be studied individually to assess correlation between VG and virulence.
Olesen et al. suggested that the expansion of ST131, and of itsH30Rx subclone in particular,
could be due more to a specific subset of genes (not necessarily encoding exclusively antibiotic
resistance or virulence) than to total number of VGs [20]. Recent whole genome analysis has
pointed to the acquisition of certain accessory genes as the starting point for the clade C (or
H30 subset) expansion [4]. Our results further refine these hypotheses, since although the
H30Rx isolates exhibited some of the highest VG and lethality scores, theH30 non-Rx (i.e.,
clade C1) isolates had lower VG scores and were significantly less virulent than even the non-
H30 isolates. Our results suggest that these subclone-specific differences in experimental viru-
lence may result from genetic differences between subclones that involve sequences other than
classic VGs. The acquisition of virulence traits, therefore, may not be the evolutionary event
that drove the clade C expansion. The distinctive accessory traits of non-RxH30 isolates,
although seemingly unlikely to confer enhanced virulence, may enhance the organism’s ability
to colonize the host or to perform other non-directly pathogenic functions that favour clonal
expansion, and so could be called more appropriately fitness traits. The limited number of
strains in our study, however, does not allow for robust conclusions, and further studies clearly
are needed.
A previous study that compared the virulence of ST131 and non-ST131 clinical isolates by
using the same murine sepsis model as used here showed that the presence of certain genes
(i.e., papAH, kpsMII, papGIII, vat, K1, and clbB/N), rather than ST131 status, was associated
with higher lethality [9]. Conversely, a recent study that compared urinary and bloodstream
isolates virulence in an insect larva model found an association of ST131 status with higher
experimental virulence [7]. Notably, however, that model has been shown to yield results that
do not correspond with those obtained in the murine sepsis model [27]. Here, in comparing
different ST131 isolates in the murine sepsis model, despite considerable overall variability in
virulence genotypes and virulence outcomes we found no significant associations between spe-
cific virulence genes and experimental virulence with the exception of the K2 gene.
Our inability to identify associations of virotype with virulence outcomes in the murine
sepsis model also differs from previous findings [10,28]. Here, although virotype C was most
common, it did not exhibit exceptionally high illness severity, lethality, or VG scores, whereas
in two previous studies by different groups of investigators it was associated with increased
mouse lethality [15,28]. We found that ST131 subclone and ExPEC status were better predic-
tors of experimental virulence than was virotype, with the association of ExPEC status and
higher lethality possibly being due to allH30Rx isolates qualifying as ExPEC. The inconsistent
in vivo virulence differences observed here among virotypes suggest that the VG combinations
that define the established virotypes do not reliably classify ST131 isolates according to their
experimental virulence in the murine sepsis model.
This study’s main limitations included the relatively small number of isolates (especially
representing theH30 non-Rx subclone), which restricted statistical power. Moreover, almost
half of the isolates were provided by two of the eight participating hospitals, although minimal
evidence of intra-hospital clonality was found. However, few studies have addressed experi-
mental virulence in relation to ST131 subclone classification, as our study does. Moreover, our
main objective was to describe the findings and generate new hypothesis for subsequent more
in-depth testing. Another possible limitation was the focus on bloodstream isolates from
Spain, which restricted generalizability. This murine model does not address completely the
pathogenesis of bloodstream infections such as previous colonization or persistence. More-
over, although this murine sepsis model is well-established, the use of presence/absence of
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virulence genes as a marker, without considering levels of expression, could affect the in vivo
virulence results.
Our study’s main strengths were the representative study population (which was drawn
broadly from different geographic areas of Spain), the inclusion of both ESBL-producing and
non-producing isolates, the wide range of tested VGs, the attention to key ST131 subclones,
and the use of a well-established murine sepsis model.
Conclusion
We found that experimental virulence in the murine sepsis model varies considerably among
ST131 isolates, even within previously defined virotypes, whereas subclone and, to a lesser
extent, ExPEC status identifies isolates with similar levels of experimental virulence. The com-
paratively high lethality ofH30Rx isolates suggests that as-yet undefined sequences associated
with this subclone might be responsible for its ability to cause severe infections. In contrast,
the comparatively low virulence of non-RxH30 isolates point away from virulence as an expla-
nation for this subgroup’s impressive epidemic emergence. Further study is needed to under-
stand the basis for ST131’s successful expansion and to find markers of experimental lethality
that also can predict clinical outcome in infected patients.
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